ReviewCurrent pain and headache reports2026
Non-Pharmacological Treatments of Migraine: Current Evidence and Clinical Practice.
Review in Current pain and headache reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purpose of reviewNon-pharmacological migraine treatments are commonly used for prevention, may be preferred in sensitive groups such as pregnancy, childhood, and older adults, can be applied as an adjunct to pharmacological treatment, or selected according to the patient condition/preferences. However, most studies are based on heterogeneous designs, resulting in uncertainties regarding level of evidence. This review aimed to summarize the current scientific evidence on the effectiveness of non-pharmacological interventions in migraine, and their role in clinical practice. RECENT
findingsRecent studies on acupuncture, physical therapy (PT), psychological therapies (PsyT), biofeedback, and neuromodulation point to modest but clinically significant benefits, although heterogeneity in outcomes and study designs limits the strength of recommendations. Articles were searched PubMed and Web of Science databases through November 2025 including acupuncture, PT, biofeedback, PsyT, and neuromodulation. Evidence levels were provided for headache frequency, intensity, duration, disability, and headache impact, with Grading of Recommendations Assessment, Development, and Evaluation (GRADE), where available. Acupuncture had a small effect on reducing monthly headache days with moderate GRADE. Aerobic exercise, manual therapy (with medical treatment), and yoga regarding PT, individually, ranged from moderate to large effects in reducing on monthly migraine days and a small to large effect size on pain intensity, duration, and disability, but did not have a GRADE. PsyT showed small imroving in monthly migraine, headache days, intensity, disability, medication use, and treatment response, with low GRADE. Evidence for neuromodulation treatments was not reported. Although there is limited evidence for efficacy in sensitive groups, PT and PsyT are approaches that can be considered for these groups due to potential positive treatment effects. These interventions have shown modest benefits in improving migraine symptoms, the overall quality and consistency of the evidence is limited and heterogeneous.
Indexed as
Identifiers
42484949What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.